Senegal - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Senegal Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 5.4% year on year. In 2019, the country was ranked number 141 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 91 Cases. India topped the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.

Loading...

Date Units (Cases)
2019 91.00
2018 86.00
2017 86.00
2016 64.00
2015 78.00
Download all data from 2007 to 2019

How does Senegal rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
141 #141
Italy
91 2019 +2.3 % -0.4 % View data
141 #141
Senegal
91 2019 +5.8 % +5.4 % View data
145 #145
Germany
90 2014 -19.6 % +5.2 % View data
Compare all 359 countries

Go Top